← Back to All US Stocks

ABPWW Stock Analysis - Abpro Holdings, Inc. AI Rating

ABPWW OTC Biological Products, (No Diagnostic Substances) DE CIK: 0001893219
Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

Abpro Holdings exhibits severe financial distress with massive operating losses (-$6.6M on $183K revenue), negative stockholders equity of -$16.1M, and critical liquidity problems (0.07x current ratio). The company is burning cash at an unsustainable rate (-$5.4M operating cash flow) with minimal revenue generation and no clear path to profitability.

ABPWW Strengths

  • + Revenue growth of 50% YoY demonstrates some commercial traction
  • + Maintains $328K in cash reserves providing short-term runway
  • + No insider selling activity in past 90 days suggests management confidence

ABPWW Risks

  • ! Negative stockholders equity of -$16.1M indicates balance sheet insolvency
  • ! Operating margin of -3582% reflects inability to scale operations profitably
  • ! Negative free cash flow of -$5.4M unsustainable; company will deplete cash within months at current burn rate
  • ! Total liabilities ($19.6M) exceed total assets ($1.7M) by 11.5x
  • ! Current ratio of 0.07x indicates severe liquidity crisis and inability to meet short-term obligations
  • ! Net margin of -4660% shows every dollar of revenue generates $46.60 in losses

Key Metrics to Watch

ABPWW Financial Metrics

Revenue
$183.0K
Net Income
$-8.5M
EPS (Diluted)
$-4.12
Free Cash Flow
$-5.4M
Total Assets
$1.7M
Cash Position
$328.0K

ABPWW Profitability Ratios

Gross Margin N/A
Operating Margin -3,582.0%
Net Margin -4,660.1%
ROE N/A
ROA -500.8%
FCF Margin -2,969.4%

ABPWW Balance Sheet & Liquidity

Current Ratio
0.07x
Quick Ratio
0.07x
Debt/Equity
N/A
Debt/Assets
1,151.3%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30 | Powered by Claude AI